TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 9 | 6 | -2 | -21 | -20 | 25 | -1 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/22/22 16:55 | 3/17/22 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leschly Nick | MA | DO | P,CEO | P.a | 4,500 | 12.20 | 0 | 369 | 196 | 557 | D | ||||||||||||||
12/9/15 16:02 | 12/8/15 | BLUE | Bluebird Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Leschly Nick | MA | DO | P,CEO | P.d | 501 | 51.75 | 33 | 10 | 3 | 330 | M | 155 | 13 | -70 | -58 | -35 | -31 | -40 | -30 | 9 | 6 | -2 | -21 | -20 | 25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |